Welcome to kongre.net
Speaker
Director of Research, Brookline Capital Markets
Kemp Dolliver, Director of Research at Brookline Capital Markets, is speaking at 8th Targeted Radiopharmaceuticals Summit Europe 2026 (London, United Kingdom, 1–3 Dec 2026) in the session “Investor Strategy Panel: From Specialist Therapy to Standard of Care: What Must Happen for RLTs to Become a Commercially Scalable Oncology Modality?”.
1–3 Dec 2026London, United Kingdom
Vice President CMC & Project Lead, OncoOne
Executive Director - Translational Research & Core Facilities ,Program Sponsor, Theranostics, UHN
Chief Executive Officer, OranoMed
Senior Expert - Strategic Therapeutic Innovation, Novartis
Chief Technology Officer, Nuclide Therapeutics
Chief Technology Officer, Norroy North America Inc.
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Kemp Dolliver, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].